The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique.

Fehlings MG, Pedro KM, Alvi MA, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, Arnold PM, Guest JD, Kurpad SN, Schuster JM, Nassr AN, Schmitt KM, Wilson JR, Brodke DS, Ahmad FU, Yee A, Ray WZ, Brooks NP, Wilson J, Chow DS, Toups EG, Thorpe KE, Huang J, Huang P

Open source

DOI: 10.1016/j.ebiom.2025.105863
Published: 2025 Aug
Container: EBioMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2025.105863,
  title = {The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique.},
  author = {Fehlings MG and Pedro KM and Alvi MA and Moghaddamjou A and Harrop JS and Stanford R and Ball J and Aarabi B and Arnold PM and Guest JD and Kurpad SN and Schuster JM and Nassr AN and Schmitt KM and Wilson JR and Brodke DS and Ahmad FU and Yee A and Ray WZ and Brooks NP and Wilson J and Chow DS and Toups EG and Thorpe KE and Huang J and Huang P},
  year = {2025},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2025.105863},
  url = {https://doi.org/10.1016/j.ebiom.2025.105863}
}

RIS

TY  - JOUR
TI  - The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique.
AU  - Fehlings MG
AU  - Pedro KM
AU  - Alvi MA
AU  - Moghaddamjou A
AU  - Harrop JS
AU  - Stanford R
AU  - Ball J
AU  - Aarabi B
AU  - Arnold PM
AU  - Guest JD
AU  - Kurpad SN
AU  - Schuster JM
AU  - Nassr AN
AU  - Schmitt KM
AU  - Wilson JR
AU  - Brodke DS
AU  - Ahmad FU
AU  - Yee A
AU  - Ray WZ
AU  - Brooks NP
AU  - Wilson J
AU  - Chow DS
AU  - Toups EG
AU  - Thorpe KE
AU  - Huang J
AU  - Huang P
PY  - 2025
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2025.105863
UR  - https://doi.org/10.1016/j.ebiom.2025.105863
ER  -

APA

MG, F., KM, P., MA, A., A, M., JS, H., R, S., J, B., B, A., PM, A., JD, G., SN, K., JM, S., AN, N., KM, S., JR, W., DS, B., FU, A., A, Y., WZ, R., NP, B., J, W., DS, C., EG, T., KE, T., J, H., & P, H. (2025). The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2025.105863

Source records

pubmed · retrieved 2026-09-26T08:53:01.740Z